1.Clinical characteristics of vibrio vulnificus infection.
Myung Geun SHIN ; Jong Hee SHIN ; Dong Wook YANG
Korean Journal of Clinical Pathology 1993;13(2):287-293
No abstract available.
Vibrio vulnificus*
;
Vibrio*
2.Evaluation of ATB 32GN system for identification of vibrio vulnificus.
Jong Hee SHIN ; Myung Geun SHIN ; Dong Wook YANG
Korean Journal of Clinical Pathology 1993;13(2):281-286
No abstract available.
Vibrio vulnificus*
;
Vibrio*
3.EXPRESSION OF TGF-alpha AND TGF-beta
Hee Chang YANG ; Dong Keun LEE ; Eun Cheol KIM
Journal of the Korean Association of Maxillofacial Plastic and Reconstructive Surgeons 1997;19(4):414-434
9,10-Dimethyl-1,2-benzanthracene
;
Animals
;
Carcinogenesis
;
Carcinoma in Situ
;
Carcinoma, Squamous Cell
;
Cricetinae
;
Cytoplasm
;
Epigenomics
;
Epithelium
;
Islands
;
Mineral Oil
;
Mouth Neoplasms
;
Mucous Membrane
;
Prognosis
;
Transforming Growth Factor alpha
;
Transforming Growth Factor beta
;
Transforming Growth Factors
4.Hidradenoma Papilliferum of the Back.
Jae Yang PARK ; Dong Ju HYUN ; Hee Jung LEE ; Dong Hyun KIM ; Moon Soo YOON
Korean Journal of Dermatology 2016;54(1):88-89
No abstract available.
Acrospiroma*
5.Extramammary Paget's Disease on the Face.
Jae Yang PARK ; Dong Ju HYUN ; Hee Jung LEE ; Dong Hyun KIM ; Moon Soo YOON
Korean Journal of Dermatology 2015;53(2):171-173
No abstract available.
Paget Disease, Extramammary*
6.Dental Fragment Embedded in the Upper Lip after Dentofacial Trauma.
Dong Ju HYUN ; Jae Yang PARK ; Hee Jung LEE ; Dong Hyun KIM ; Moon Soo YOON
Korean Journal of Dermatology 2015;53(10):811-812
No abstract available.
Lip*
7.Truncus Arteriosus Associated with Interrupted Aortic Arch.
Chang Hyun YANG ; Jae Seung YANG ; Jun Hee SUL ; Dong Soo KIM ; Sung Kyu LEE ; Dong Shik CHIN
Journal of the Korean Pediatric Society 1988;31(6):779-783
No abstract available.
Aorta, Thoracic*
;
Truncus Arteriosus*
8.A Case of Cutaneous Lymphadenoma.
Jae Yang PARK ; Seong Rak SEO ; Hee Jung LEE ; Dong Hyun KIM ; Moon Soo YOON
Korean Journal of Dermatology 2016;54(1):83-85
No abstract available.
9.A Pathological Review of Pleural Effusion by Immunocytochemical Methods.
Dong Hwan SHIN ; Hee Jeong AHN ; Woo Ick YANG ; In Joon CHOI
Korean Journal of Pathology 1990;24(4):476-481
An unequivocal diagnosis of mesothelioma during life, on the basis of limited biopsy tissue or cytological specimens, is frequently difficult and requires distinction from inflammatory mesothelial hyperplasia on the one hand and secondary neoplasms, especially adenocarcinoma on the other. Although some studies have produced conflicting results, it is generally believed that immunohistochemical methods can aid in this distinction. To obtain comparable and reproducible results, 23 metastatic carcinoma of the pleura and 2 unequivocal malignant epiehtlial mesotheliomas were studied by the peroxidase-antiperoxedase method on paraffin-embedded cell blocks, and commercially available antibodies to carcinoembryonic antigen (CEA), keratin and epithelial membrane antigen (EMA) were used. Nineteen metastaic adenocarcinoma (73%) and two mesotheliomas (100%) reacted with keratin and EMA antibodies. Nineteen matastatic adenocarcinomas (73%) reacted with EMA antibodies. Nineteen metastatic adenocarcinoma (73%) reacted with CEA antibody; no mesotheliomas stained for CEA. Two cases of reactive mesothlial hyperplasia showed positive for keratin, but negative reaction for EMA and CEA. Noen of the antibodies used in this study was specific for mesothelioma, but CEA was found to be the most useful marker for differentiating between mesothelioma and metastatic carcinoma.
Adenocarcinoma
;
Biopsy
;
Neoplasm Metastasis
10.A Pathological Review of Pleural Effusion by Immunocytochemical Methods.
Dong Hwan SHIN ; Hee Jeong AHN ; Woo Ick YANG ; In Joon CHOI
Korean Journal of Pathology 1990;24(4):476-481
An unequivocal diagnosis of mesothelioma during life, on the basis of limited biopsy tissue or cytological specimens, is frequently difficult and requires distinction from inflammatory mesothelial hyperplasia on the one hand and secondary neoplasms, especially adenocarcinoma on the other. Although some studies have produced conflicting results, it is generally believed that immunohistochemical methods can aid in this distinction. To obtain comparable and reproducible results, 23 metastatic carcinoma of the pleura and 2 unequivocal malignant epiehtlial mesotheliomas were studied by the peroxidase-antiperoxedase method on paraffin-embedded cell blocks, and commercially available antibodies to carcinoembryonic antigen (CEA), keratin and epithelial membrane antigen (EMA) were used. Nineteen metastaic adenocarcinoma (73%) and two mesotheliomas (100%) reacted with keratin and EMA antibodies. Nineteen matastatic adenocarcinomas (73%) reacted with EMA antibodies. Nineteen metastatic adenocarcinoma (73%) reacted with CEA antibody; no mesotheliomas stained for CEA. Two cases of reactive mesothlial hyperplasia showed positive for keratin, but negative reaction for EMA and CEA. Noen of the antibodies used in this study was specific for mesothelioma, but CEA was found to be the most useful marker for differentiating between mesothelioma and metastatic carcinoma.
Adenocarcinoma
;
Biopsy
;
Neoplasm Metastasis